GLOBAL RABBIT CARDIOVASCULAR IMAGING SYSTEM MARKET

INTRODUCTION

The macroscopic materialisation of myocardial microstructure and its significance for heart function are essential.

Despite this significance, it is still difficult to characterise cellular properties at the organ level, and a comprehensive description of the heart's structure is still lacking.

The method of perfusing the isolated heart in vitro has had a significant impact on cardiac function for more than a century.

Large animals like dogs and pigs were frequently used in animal models for acute, subacute, and chronic myocardial infarction.

Recently, rabbits, rats, and mice have also been used as models since they are inexpensive, may be used in many investigations, and are simple to house during the trial.

GLOBAL RABBIT CARDIOVASCULAR IMAGING SYSTEM MARKET SIZE AND FORECAST

The Global Rabbit cardiovascular imaging system market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2022 to 2030.

NEW PRODUCT LAUNCH

With the Quantum GX2 microCT imaging equipment, one can see beyond bone and into cancer, cardiovascular and pulmonary illnesses, and much more.

The Quantum GX2 requires a lot of versatility. The Quantum GX2 microCT imaging system combines high speed, low dose scans—perfect for longitudinal studies—across multiple species (mice, rats, and rabbits) with high resolution ex vivo scanning to give performance and flexibility needed to not only image, but also better understand rabbit disease models.

A complete multispecies preclinical imaging system, the Quantum GX2 microCT scanner has the flexibility to permit both ex vivo sample scanning and longitudinal in vivo imaging.

A complete rabbit can be scanned in vivo using the 163mm imaging bore, and ex vivo samples can be scanned in high resolution using the 18mm FOV.

The Quantum GX2 microCT imaging system offers the greatest degree of versatility and functionality when used in conjunction with PerkinElmer's 3-dimensional optical imaging systems and automated bone analysis software (AccuCTTM).

The Quantum GX2 is adaptable enough to provide the results required, regardless of the research focus—oncology, cardiovascular disease, orthopaedics, or pulmonary illness.

COMPANY PROFILE

• Vetoquinol S.A
• IDVet
• Bayer AG
• Boehringer-Ingelheim
• Ceva Santé Animale
• Merck

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

1. What is the average cost perGlobal Rabbit cardiovascular imaging system marketright now and how will it change in the next 5-6 years?
2. Average cost to set up aGlobal Rabbit cardiovascular imaging system marketin the US, Europe and China?
3. How manyGlobal Rabbit cardiovascular imaging system marketare manufactured per annum globally? Who are the sub-component suppliers in different regions?
4. What is happening in the overall public, globally?
5. Cost breakup of aGlobal Rabbit cardiovascular imaging system marketand key vendor selection criteria
6. Where is theGlobal Rabbit cardiovascular imaging system marketmanufactured? What is the average margin per equipment?
7. Market share ofGlobal Rabbit cardiovascular imaging system marketmanufacturers and their upcoming products
8. The most important plannedGlobal Rabbit cardiovascular imaging system marketin next 2 years
9. Details on network of majorGlobal Rabbit cardiovascular imaging system marketand pricing plans
10. Cost advantage for OEMs who manufactureGlobal Rabbit cardiovascular imaging system marketin-house
11. 5 key predictions for next 5 years inGlobal Rabbit cardiovascular imaging system market
12. Average B-2-BGlobal Rabbit cardiovascular imaging system marketprice in all segments
13. Latest trends inGlobal Rabbit cardiovascular imaging system market, by every market segment
14. The market size (both volume and value) ofGlobal Rabbit cardiovascular imaging system marketin 2022-2030 and every year in between?
15. Global production breakup ofGlobal Rabbit cardiovascular imaging system market, by suppliers and their OEM relationship.